Prostate Cell News Volume 15.15 | Jun 14 2024

    0
    84







    2024-06-14 | PCN 15.15


    Prostate Cell News by STEMCELL Technologies
    Vol. 15.15 – 14 June, 2024
    TOP STORY

    PSCA-CAR T Cell Therapy in Metastatic Castration-Resistant Prostate Cancer: A Phase I Trial

    Scientists reported results from a Phase II, first-in-human study of prostate stem cell antigen (PSCA)-directed CAR T cells in men with metastatic castration-resistant prostate cancer.
    [Nature Medicine]

    Full Article
    Download these free lab templates to increase your efficiency as a life science researcher.
    PUBLICATIONSRanked by the impact factor of the journal

    RNASEH2B Loss and PARP Inhibition in Advanced Prostate Cancer

    Whole tumor biopsies from multiple cohorts of patients with advanced prostate cancer were interrogated using whole-exome sequencing, RNA sequencing, and immunohistochemistry for RNASEH2B and RB1.
    [Journal of Clinical Investigation]

    AbstractGraphical Abstract

    FOXA2 Rewires AP-1 for Transcriptional Reprogramming and Lineage Plasticity in Prostate Cancer

    Investigators demonstrated that forkhead box A (FOXA) 2 bound to distinct classes of developmental enhancers in multiple androgen receptor-independent prostate cancer subtypes, with its binding depending on lysine-specific demethylase 1.
    [Nature Communications]

    Full Article

    CDK4/6 Alters TBK1 Phosphorylation to Inhibit the STING Signaling Pathway in Prostate Cancer

    Scientists found that treatment with CDK4/6 inhibitors stimulated the STING pathway and enhanced the antitumor effect of STING agonists in prostate cancer.
    [Cancer Research]

    Abstract

    Batf-Dependent Th17 Cells Act through IL23R Pathway to Promote Prostate Adenocarcinoma Initiation and Progression

    Researchers characterized the role of Batf-dependent Th17 cells in prostate cancer by crossbreeding Batf knockout mice with mice conditionally mutant for Pten.
    [JNCI-Journal of The National Cancer Institute]

    Abstract

    CAPN2 Promotes Apalutamide Resistance in Metastatic Hormone-Sensitive Prostate Cancer by Activating Protective Autophagy

    Investigators established apalutamide-resistant prostate cancer cells, and confirmed that apalutamide activated the release of calcium ions and endoplasmic reticulum stress to enhance autophagy.
    [Journal of Translational Medicine]

    Full Article

    FOXO3a/PI3K/Akt Pathway Participates in the ROS-Induced Apoptosis Triggered by α-ZEL and β-ZEL

    The authors evaluated the direct molecular effect of α-zearalenol (ZEL) and β-ZEL in a dose of 30 µM in hormone-dependent human prostate cancer cells with the focus of the involvement of forehead box transcription factor 3a (FOXO3a) and PI3K/Akt signaling pathway in that effect.
    [Scientific Reports]

    Full Article

    Deciphering the Role of Zinc Homeostasis in the Tumor Microenvironment and Prognosis of Prostate Cancer

    The zinc homeostasis pattern subtype was constructed according to the profile of zinc homeostasis genes. The identified subtypes were assessed for their immune functions, mutational landscapes, biological peculiarities and drug susceptibility.
    [Discover Oncology]

    Full Article

    Prognostic Marker VPS72 Could Promote the Malignant Progression of Prostate Cancer

    Clinical information and gene expression profiles of patients with prostate cancer (PCa) were obtained from The Cancer Genome Atlas. Vacuolar protein sorting-associated protein 72 homolog (VPS72) expression in PCa and the potential mechanism by which VPS72 affected PCa progression was investigated.
    [BMC Cancer]

    Full Article
    Learn about key considerations for using EasySepâ„¢ products and tips & tricks to avoid the most commonly made mistakes.
    REVIEWS

    Mesenchymal Stem Cell-Derived Exosomes for Management of Prostate Cancer: An Updated View

    In prostate cancer, researchers have explored the fact that mesenchymal stem cell (MSC)-based therapies and MSC-derived exosomes are emerging as attractive options to improve the efficacy and safety of traditional cancer therapies.
    [International Immunopharmacology]

    Abstract
    INDUSTRY AND POLICY NEWS

    Increasing Access to Prostate Cancer Care

    Alberta’s government is partnering with the Alberta Cancer Foundation to deliver improved diagnosis outcomes for Albertans who have prostate cancer.
    [Government of Alberta]

    Press Release
    FEATURED EVENT

    Cell Signaling in Cancer: From Mechanisms to Therapy

    June 16 – 20, 2024
    Tucson, Arizona, United States

    > See All Events

    JOB OPPORTUNITIES

    Clinical Educator – Genitourinary Malignancies

    Northwestern University – Chicago, Illinois, United States

    Professor – Science Research

    KU Leuven – Leuven, Belgium

    Postdoctoral Fellow – Cancer Inequities

    EMBL-European Bioinformatics Institute – Cambridge, England, United Kingdom

    Research Fellow – Health and Life Sciences

    Northumbria University – Newcastle, England, United Kingdom

    Research Specialist – Prostate Cancer Pathology

    University of Wisconsin–Madison – Madison, Wisconsin, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2